|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02096 SIMCERE PHARMA
Nominal 
11.630 -0.140 (-1.189%) Ranking Overview
Ranking based on 5 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
5
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2025 | EPS | 54.00 RMB (cts) | |
| Net Profit | 1,344.01 RMB (MIL) | DPS | 18.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2026 | 1,753.00 | 68.00 | 26.13 | -- | 1,833.00 | 1,654.00 |
| 2027 | 2,173.00 | 85.00 | 31.08 | -- | 2,257.00 | 1,928.00 |
| 2028 | 2,463.00 | 95.00 | 36.49 | -- | 2,556.00 | 2,075.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2026 | 1,833.00 | 71.00 | 26.13 | HUATAI FIN HLDGS HK | Buy | 21.46 | 02/09/2026 | |
| 2026 | 1,686.00 | 65.00 | -- | CITIC SEC | Buy | 20.00 | 31/08/2026 | |
| 2026 | 1,654.00 | 63.90 | -- | BOCOM | Buy | 20.00 | 24/08/2026 | |
| 2026 | 1,753.00 | 70.80 | 21.30 | BOCI | Buy | 17.00 | 03/08/2026 | |
| 2026 | 1,766.00 | 68.00 | 36.00 | UBS | Buy | 16.60 | 01/09/2026 | |
| 2027 | 2,173.00 | 85.00 | 31.08 | HUATAI FIN HLDGS HK | -- | -- | 02/09/2026 | |
| 2027 | 2,253.00 | 87.50 | -- | BOCOM | -- | -- | 24/08/2026 | |
| 2027 | 2,016.00 | 78.00 | -- | CITIC SEC | -- | -- | 31/08/2026 | |
| 2027 | 2,257.00 | 91.20 | 27.40 | BOCI | -- | -- | 03/08/2026 | |
| 2027 | 1,928.00 | 74.00 | 41.00 | UBS | -- | -- | 01/09/2026 | |
| 2028 | 2,556.00 | 100.00 | 36.49 | HUATAI FIN HLDGS HK | -- | -- | 02/09/2026 | |
| 2028 | 2,463.00 | 95.00 | -- | CITIC SEC | -- | -- | 31/08/2026 | |
| 2028 | 2,075.00 | 80.60 | -- | BOCOM | -- | -- | 24/08/2026 | |
| 2028 | 2,513.00 | 101.50 | 30.50 | BOCI | -- | -- | 03/08/2026 | |
| 2028 | 2,268.00 | 87.00 | 48.00 | UBS | -- | -- | 01/09/2026 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 04/09/2026 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 828,720 |
| %Change | 37.878% |
| EPS / (LPS) | RMB 0.320 |
| NBV Per Share (¥) | RMB 3.670 |